Complete funding guide for life sciences entrepreneurs in Israel. Find 13 VC funds, 5 accelerators,2 angel networks, and 4 grant opportunities.
The life sciences startup ecosystem in Israel has experienced remarkable growth, with $555M in funding across 134 deals in 2025.This represents 11% year-over-year growth compared to the previous year, positioning Israelas a emerging market forlife sciences innovation.
The average funding round size of $6M reflects strong investor confidence in Israel-based life sciences startups. Competition levels are currently very high, with 13 active VC funds specifically targeting this sector.
Israel offers a concentrated life sciences ecosystem with specialized talent
Strong government support for life sciences innovation and R&D tax incentives
Access to leading universities and research institutions in the region
Lower operational costs compared to traditional tech hubs like San Francisco
series-b stage focus • 39 portfolio companies
series-a stage focus • 36 portfolio companies
series-b stage focus • 46 portfolio companies
series-a stage focus • 38 portfolio companies
series-b stage focus • 25 portfolio companies
series-a stage focus • 48 portfolio companies
series-b stage focus • 48 portfolio companies
series-b stage focus • 42 portfolio companies
series-a stage focus • 21 portfolio companies
series-b stage focus • 69 portfolio companies
series-a stage focus • 32 portfolio companies
series-b stage focus • 61 portfolio companies
series-a stage focus • 64 portfolio companies
by Israel Innovation Agency
Life Sciences startups based in Israel
by Israel Innovation Agency
Life Sciences startups based in Israel
by Israel Innovation Agency
Life Sciences startups based in Israel
by Israel Innovation Agency
Life Sciences startups based in Israel
Strong funding activity as VCs deploy fresh capital from annual fund raises
Peak investment period with increased deal velocity and accelerator demo days
Moderate activity as partners focus on portfolio company support during summer
Year-end push to deploy remaining capital and close pending deals
Life Sciences startup funding in Israel is very high, with 13 active VC funds and 5 accelerator programs competing for deals. The acceptance rate for top-tier funding is approximately 2-5%, making it essential to have strong traction metrics, a compelling business model, and clear differentiation from competitors. Success factors includeDeep expertise in life sciences domain, Strong technical team with proven track record, Clear market validation and customer traction.
Life Sciences startups in Israel raise an average of $6M per funding round, based on 134 deals completed in 2025. This represents 11% year-over-year growthcompared to the previous year. Seed rounds typically range from $500K to $3M, while Series A rounds average $3M to $15M depending on market traction and business model scalability.
Top life sciences accelerators in Israel report success rates of 75-85% for follow-on funding, with program lengths ranging from 12-16 weeks and equity terms of 4-7%. The most successful programs focus onlife-sciences and startup-growthand provide extensive mentor networks, investor connections, and post-graduation support lasting 2+ years.
Israel offers several unique advantages for life sciences startups: Israel offers a concentrated life sciences ecosystem with specialized talent, Strong government support for life sciences innovation and R&D tax incentives, and Access to leading universities and research institutions in the region. The local ecosystem includes 13 specialized VC funds, 2 angel networks, and 4 grant programs specifically supporting life sciences innovation.
The optimal fundraising months in Israel are February, March, May, when investor activity peaks and deal velocity increases. Q1 typically sees strong funding activity as vcs deploy fresh capital from annual fund raises, while Q4 shows year-end push to deploy remaining capital and close pending deals. Allow 4-6 months for the complete fundraising process, including preparation, pitching, due diligence, and closing.
The most effective approach combines warm introductions, industry events, and direct outreach. Start by leveraging your network for introductions to the 13 active VC funds in Israel. Join relevant life sciences meetups, attend pitch competitions, and participate in accelerator demo days. Angel networks like Israel Life Sciences Angels host regular investor meetings and can provide valuable early-stage funding and mentorship.
Last updated: 10/20/2025 | Data aggregated from 13 VC funds, 5 accelerators, and 2 angel networks |About our methodology